
Company valuation, historical trends, and peer comparisons.
According to Viridian Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.85B. This represents a change of 41.91% compared to the average of 2.01B of the last 4 quarters.
The mean historical Enterprise Value of Viridian Therapeutics, Inc. over the last ten years is 586.87M. The current 2.85B Enterprise Value has changed 385.46% with respect to the historical average. Over the past ten years (40 quarters), VRDN's Enterprise Value was at its highest in in the December 2025 quarter at 2.48B. The Enterprise Value was at its lowest in in the March 2020 quarter at -8148552.36.
Average
586.87M
Median
178.79M
Minimum
-1500523.20
Maximum
2.48B
Discovering the peaks and valleys of Viridian Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.39%
Maximum Annual Enterprise Value = 2.48B
Minimum Annual Increase = -971.14%
Minimum Annual Enterprise Value = -1500523.20
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.48B | 102.59% |
| 2024 | 1.22B | 36.94% |
| 2023 | 893.00M | 13.48% |
| 2022 | 786.95M | 304.86% |
| 2021 | 194.37M | 1.39% |
| 2020 | 13.07M | -971.14% |
| 2019 | -1500523.20 | -102.23% |
| 2018 | 67.38M | -58.71% |
| 2017 | 163.20M | 214.35% |
| 2016 | 51.92M | -35.95% |
The current Enterprise Value of Viridian Therapeutics, Inc. (VRDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.53B
5-year avg
1.11B
10-year avg
586.87M
Viridian Therapeutics, Inc.’s Enterprise Value is greater than Outlook Therapeutics, Inc. (123.90M), greater than EyePoint Pharmaceuticals, Inc. (-56533135.00), greater than Ocular Therapeutix, Inc. (958.93M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 123.90M | $116.71M | |
| -56533135.00 | $31.56M | |
| 958.93M | $1.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viridian Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Viridian Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Viridian Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Viridian Therapeutics, Inc. (VRDN)?
What is the 3-year average Enterprise Value for Viridian Therapeutics, Inc. (VRDN)?
What is the 5-year average Enterprise Value for Viridian Therapeutics, Inc. (VRDN)?
How does the current Enterprise Value for Viridian Therapeutics, Inc. (VRDN) compare to its historical average?